Ambalal Sarabhai Enterprises Ltd.

NSE: AMBASARABH BSE: 500009 SECTOR: Pharmaceuticals & Drugs

34.3
-1.6 (-4.46%)
BSE: 18 Jun 05:26 PM

Price Summary

Today's High

₹ 37.35

Today's Low

₹ 34.15

52 Week High

₹ 65

52 Week Low

₹ 15.7

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

262.85 Cr.

Enterprise Value

269.36 Cr.

No. of Shares

7.66 Cr.

P/E

0

P/B

8.52

Face Value

₹ 10

Div. Yield

0%

Book Value (TTM)

₹  4.03

CASH

4.49 Cr.

DEBT

11 Cr.

Promoter Holding

30.76%

EPS (TTM)

₹  -1.22

Sales Growth

0%

ROE

47.82 %

ROCE

37.59 %

Profit Growth

500.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Ratios

Sales Growth

1 YearNA
3 Year-100%
5 Year-100%

Profit Growth

1 Year500.76%
3 Year40.21%
5 Year29.9%

ROE%

1 Year47.82%
3 Year9.47%
5 Year30.43%

ROCE %

1 Year37.59%
3 Year12.39%
5 Year23.91%

Debt/Equity

0.2733

Price to Cash Flow

-57.97

Interest Cover Ratio

35.2246610716591

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2021 30.76 0
Dec 2020 30.76 0
Sep 2020 30.76 0
Jun 2020 30.76 0
Mar 2020 30.76 0
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -1770.01940105462 days.

 Limitations

  • The company has shown a poor revenue growth of -100% for the Past 3 years.
  • Company has contingent liabilities of 57.3007 Cr.
  • Company has negative cash flow from operations of -4.5346.
  • The company has a low EBITDA margin of -778.316522559923% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
Net Sales 0 0 0 0 0
Total Expenditure 1.11 1.1 1.54 1.45 34.06
Operating Profit -1.11 -1.1 -1.54 -1.45 -34.06
Other Income 16 1.51 1.86 0.96 25.29
Interest 0.16 0.12 0.16 0.15 0.12
Depreciation 0.1 0.1 0.09 0.1 0.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.63 0.19 0.07 -0.74 -8.99
Tax 1.06 0.01 -0.03 -0.01 -0.06
Profit After Tax 13.58 0.18 0.1 -0.73 -8.94
Adjusted EPS (Rs) 1.77 0.02 0.01 -0.1 -1.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 6.99 1.51 0.92 0 0
Total Expenditure 28.63 22.13 21.77 8.87 7.85
Operating Profit -21.64 -20.62 -20.85 -8.87 -7.85
Other Income 95.94 7.03 24.49 6.46 24.61
Interest 1.99 2.62 1.05 0.62 0.46
Depreciation 14.62 2.45 0.42 0.4 0.39
Exceptional Items 0 0 0 0 0
Profit Before Tax 57.68 -18.66 2.19 -3.42 15.9
Tax 12 1.9 3.63 0.46 0.35
Net Profit 45.68 -20.57 -1.44 -3.88 15.55
Adjusted EPS (Rs.) 5.96 -2.68 -0.19 -0.51 2.03

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 76.63 76.63 76.63 76.63 76.63
Total Reserves -27.8 -46.41 -47.98 -51.85 -36.39
Borrowings 0 0 0 0 0
Other N/C liabilities 3.66 0.38 0.16 0.02 0.2
Current liabilities 104.27 82.63 99.56 111.63 82.23
Total Liabilities 156.76 113.23 128.37 136.43 122.68
Assets
Net Block 20.6 16.43 14.98 14.65 14.48
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 82.91 76.19 67.27 67.36 64.77
Loans & Advances 0.4 0 0 0 0
Other N/C Assets 0.07 0 0 0 0
Current Assets 52.78 20.61 46.11 54.42 43.43
Total Assets 156.76 113.23 128.37 136.43 122.68
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit from operations 57.68 -18.66 2.19 -3.42 15.9
Adjustment -73.2 5.36 -14.94 -1.53 -21.64
Changes in Assets & Liabilities -50.37 9.86 17.7 5.96 1.69
Tax Paid -3.48 -0.23 -17.6 -4.28 -0.49
Operating Cash Flow -69.37 -3.67 -12.66 -3.27 -4.53
Investing Cash Flow 75.22 8.64 26.14 2.37 4.92
Financing Cash Flow -2.56 -8.14 -12.15 -0.44 -0.42
Net Cash Flow 3.3 -3.17 1.33 -1.33 -0.03

Corporate Actions

Investors Details

PARTICULARS Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
Promoters 30.76 30.76 30.76 30.76 30.76
Adana Investments Pvt.Ltd... 0.21 0 0.21 0.21 0.21
Ashavari Investments Pvt.... 0 0 0.24 0.24 0.24
Bilawal Investments Pvt.L... 0.21 0 0.21 0.21 0.21
Jonpuri Investments Pvt.L... 0.23 0 0.23 0.23 0.23
Khamaj Investments Pvt.Lt... 0.21 0 0.21 0.21 0.21
Koshalya Investments Pvt.... 0.6 0 0 0 0
Leena Investments Pvt.Ltd... 0.17 0 0 0 0
Sahayog Investments Pvt.L... 0.21 0 0.21 0.21 0.21
Talimi Investments Pvt.Lt... 0 0 0.21 0.21 0.21
Vaishakhi Investments Pvt... 0.24 0 0.24 0.24 0.24
Vasantbahar Investments P... 0 0 0 0.26 0.26
Bhadrapad Investments Pvt... 0.21 0 0.21 0.21 0.21
Kanda Investments Pvt.Ltd... 0.27 0 0.27 0.27 0.27
Kartikeya Vikram Sarabhai... 0.16 0.16 0.16 0.16 0.16
Madhavbag Holdings Pvt.Lt... 0.23 0 0.23 0.23 0.23
Mallika Vikram Sarabhai 0.16 0.16 0.16 0.16 0.16
Mohal Kartikeya Sarabhai 0.07 0.07 0.07 0.07 0.07
Mrigank Investments Pvt.L... 0.23 0 0.23 0.23 0.23
Samvit Kartikeya Sarabhai... 0.06 0.06 0.06 0.06 0.06
Todirag Holdings Pvt.Ltd.... 0.24 0 0.24 0.24 0.24
Yudhisthar Investments Pv... 0.61 0 0 0 0
ASHAVARI INVESTMENTS PVT.... 0 0 0.24 0.24 0.24
BILAWAL INVESTMENTS PVT.L... 0.21 0 0.21 0.21 0.21
KANDA INVESTMENTS PVT.LTD... 0.27 0 0.27 0.27 0.27
KHAMAJ INVESTMENTS PVT.LT... 0.21 0 0.21 0.21 0.21
KOSHALYA INVESTMENTS PVT.... 0.6 0 0 0 0
MADHAVBAG HOLDINGS PVT.LT... 0.23 0 0.23 0.23 0.23
MALLIKA VIKRAM SARABHAI 0.16 0.16 0.16 0.16 0.16
MRIGANK INVESTMENTS PVT.L... 0.23 0 0.23 0.23 0.23
SAMVIT KARTIKEYA SARABHAI... 0.06 0.06 0.06 0.06 0.06
TALIMI INVESTMENTS PVT.LT... 0 0 0.21 0.21 0.21
ADANA INVESTMENTS PVT.LTD... 0.21 0 0.21 0.21 0.21
BHADRAPAD INVESTMENTS PVT... 0.21 0 0.21 0.21 0.21
JONPURI INVESTMENTS PVT.L... 0.23 0 0.23 0.23 0.23
KARTIKEYA VIKRAM SARABHAI... 0.16 0.16 0.16 0.16 0.16
LEENA INVESTMENTS PVT.LTD... 0.17 0 0 0 0
MEDICINAL DRUGS MFG PVT.L... 0.21 0 0 0 0
MOHAL KARTIKEYA SARABHAI 0.07 0.07 0.07 0.07 0.07
RAJKA DESIGNS PVT.LTD 0.21 0 0 0 0
SAHAYOG INVESTMENTS PVT.L... 0.21 0 0.21 0.21 0.21
SARABHAI HOLDINGS PVT.LTD... 25.19 0 0 0 0
SARABHAI MANAGEMENT CORP ... 0.12 0 0 0 0
TALIMI INVESTMENTS PVT.LT... 0.21 0 0 0 0
TODIRAG HOLDINGS PVT.LTD.... 0.24 0 0.24 0.24 0.24
VAISHAKHI INVESTMENTS PVT... 0.24 0 0.24 0.24 0.24
YUDHISTHAR INVESTMENTS PV... 0.61 0 0 0 0
ASHAVARI INVESTMENTS PVT.... 0.24 0.24 0 0 0
VASANTBAHAR INVESTMENTS P... 0.26 0 0 0 0
Adana Investments Pvt. Lt... 0 0.21 0 0 0
Ashavari Investments Pvt.... 0.24 0.24 0 0 0
Bhadrapad Investments Pvt... 0 0.21 0 0 0
Bilawal Investments Pvt. ... 0 0.21 0 0 0
Jonpuri Investments Pvt. ... 0 0.23 0 0 0
Kanda Investments Pvt. Lt... 0 0.27 0 0 0
Khamaj Investments Pvt. L... 0 0.21 0 0 0
Koshalya Investments Pvt.... 0 0.6 0 0 0
Leena Investments Pvt. Lt... 0 0.17 0 0 0
Madhavbag Holdings Pvt. L... 0 0.23 0 0 0
Medicinal Drugs Mfg. Pvt.... 0 0.21 0 0 0
Mrigank Investments Pvt. ... 0 0.23 0 0 0
Rajka Designs Pvt. Ltd 0 0.21 0 0 0
Sahayog Investments Pvt. ... 0 0.21 0 0 0
Sarabhai Holdings Pvt. Lt... 0 25.19 0 0 0
Sarabhai Management Corp ... 0 0.12 0 0 0
Talimi Investments Pvt. L... 0 0 0 0 0
Todirag Holdings Pvt. Ltd... 0 0.24 0 0 0
Vaishakhi Investments Pvt... 0 0.24 0 0 0
Vasantbahar Investments P... 0 0.26 0 0 0
Yudhisthar Investments Pv... 0 0.61 0 0 0
Talimi Investments Pvt. L... 0 0.21 0 0 0
KOSHALYA INVESTMENTS PVT ... 0 0 0.6 0.6 0.6
LEENA INVESTMENTS PVT LTD... 0 0 0.17 0.17 0.17
MEDICINAL DRUGS MFG.PVT.L... 0 0 0.21 0.21 0.21
RAJKA DESIGNS PRIVATE LIM... 0 0 0.21 0.21 0.21
SARABHAI HOLDINGS PRIVATE... 0 0 25.19 25.19 25.19
SARABHAI MANAGEMENT CORPO... 0 0 0.12 0.12 0.12
VASANTBAHAR INVESTMENTS P... 0 0 0.26 0 0
YUDHISTHAR INVESTMENTS PV... 0 0 0.61 0.61 0.61
VASANTBAHAR INVESTMENTS P... 0 0 0 0.26 0.26
PARTICULARS Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
Public 69.24 69.24 69.24 69.24 69.24
CAPLIN VINIYOG PRIVATE LI... 5.51 5.51 5.51 5.51 5.51
MONEST SECURITIES PRIVATE... 2.64 0 0 0 0
NAVTECH FARM PRODUCTS PRI... 4.76 4.76 4.76 4.76 4.76
ONTIME HIRE PURCHASE AND ... 4.3 4.3 4.3 4.3 4.3
Caplin Viniyog Private Li... 5.51 5.51 5.51 5.51 5.51
Monet Securities Private ... 0 2.64 0 0 0
Navtech Farm Products Pri... 4.76 4.76 4.76 4.76 4.76
Ontime Hire Purchase and ... 4.3 4.3 4.3 4.3 4.3
M. PRASAD & CO. LIMITED 1.27 0 0 0 0
M. Prasad & Co Limited 0 1.27 0 0 0
M.PRASAD & CO LIMITED 0 0 1.27 1.27 1.27
MONET SECURITIES PRIVATE ... 0 0 2.97 2.97 2.97
PARTICULARS Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
FII/DII 0.01 0.01 0.01 0.01 0.01

Ratings & Research Reports

No Credit and Research reports exist for this company.
Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Ambalal Sarabhai Ent Stock Price Analysis and Quick Research Report. Is Ambalal Sarabhai Ent an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Ambalal Sarabhai Ent and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs -4.5346 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Ambalal Sarabhai Ent has a Debt to Equity ratio of 0.2733 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Ambalal Sarabhai Ent , the EPS growth was 500.790045427612 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Ambalal Sarabhai Ent has OPM of 0 % which is a bad sign for profitability.
     
  • ROE: Ambalal Sarabhai Ent have a healthy ROE of 47.8248567588597 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Ambalal Sarabhai Ent

X